Common use of IND Clause in Contracts

IND. The term “IND” shall mean an Investigational New Drug Application filed with the FDA, or the equivalent application or filing filed with any equivalent Regulatory Authority outside the United States of America (including any supra-national agency, such as in the European Union) necessary to commence human clinical trials in such jurisdiction.

IND. The term “IND” shall mean an Investigational New Drug Application investigational new drug application, clinical trial application, clinical trial exemption, or similar application or submission for approval to conduct human clinical investigations filed with the FDA, or the equivalent application or filing filed with submitted to a regulatory authority in any equivalent Regulatory Authority outside the United States of America (including any supra-national agency, such as in the European Union) necessary to commence human clinical trials in such jurisdictioncountry.

IND. The term “IND” shall mean an Investigational New Drug Application Application, as defined in the FD&C Act, that is required to be filed with the FDAFDA before beginning clinical testing in human subjects, or the an equivalent application or filing filed with any equivalent Regulatory Authority outside the United States of America (including any supra-national agency, such as in the European Union) necessary to commence human clinical trials in such jurisdictionforeign filing.